Long-Term Anatomical and Functional Survival of Boston Type 1 Keratoprosthesis in Congenital Aniridia
暂无分享,去创建一个
[1] A. Soldevila,et al. Transmucosal Boston Keratoprosthesis Type I in a Patient With Advanced Ocular Cicatricial Pemphigoid. , 2020, Cornea.
[2] J. Sugar,et al. Management of Congenital Aniridia-Associated Keratopathy: Long-Term Outcomes from a Tertiary Referral Center. , 2019, American journal of ophthalmology.
[3] G. Grabner,et al. Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease. , 2019, The ocular surface.
[4] N. Subramanian,et al. Keratoprosthesis: Current global scenario and a broad Indian perspective , 2018, Indian journal of ophthalmology.
[5] M. S. Cortina,et al. Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study , 2018, PloS one.
[6] E. Holland,et al. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia , 2018, Cornea.
[7] J. Chodosh,et al. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation. , 2017, Ophthalmology.
[8] B. Chauhan,et al. Congenital aniridia: etiology, manifestations and management , 2016, Expert review of ophthalmology.
[9] M. Belin,et al. Suggested Guidelines for Reporting Keratoprosthesis Results: Consensus Opinion of the Cornea Society, Asia Cornea Society, EuCornea, PanCornea, and the KPRO Study Group , 2016, Cornea.
[10] M. Harissi-Dagher,et al. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. , 2014, American journal of ophthalmology.
[11] P. Song,et al. CLINICAL OUTCOMES? , 2014 .
[12] K. Goins,et al. Treatment of Aniridia With Boston Type I Keratoprosthesis , 2013, Cornea.
[13] E. Holland,et al. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. , 2012, American journal of ophthalmology.
[14] M. Belin,et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. , 2012, Ophthalmology.
[15] J. Chodosh,et al. Titanium back plate for a PMMA keratoprosthesis: clinical outcomes , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.
[16] D. Hu,et al. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy. , 2008, American journal of ophthalmology.
[17] R. Pineda,et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. , 2007, American journal of ophthalmology.